Tumor Targeted Delivery of an Anti-Cancer Therapeutic: An In Vitro and In Vivo Evaluation
- 1 January 2021
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (2), e2001261
- https://doi.org/10.1002/adhm.202001261
Abstract
The limited effectiveness of current therapeutics against malignant brain gliomas has led to an urgent need for development of new formulations against these tumors. Chelator Dp44mT (di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone) presents a promising candidate to defeat gliomas due to its exceptional anti-tumor activity and its unique ability to overcome multidrug resistance. The goal of this study is to develop a targeted nano-carrier for Dp44mT delivery to glioma tumors and to assess its therapeutic efficacy in vitro and in vivo. Dp44mT is loaded into poly(ethylene glycol) (PEG)ylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) decorated with glioma-targeting ligand Interlukin 13 (IL13). IL13-conjugation enhanced the NP uptake by glioma cells and also improved their transport across an in vitro blood-brain-barrier (BBB) model. This targeted formulation showed an outstanding toxicity towards glioma cell lines and patient-derived stem cells in vitro, with IC50 values less than 125 nM, and caused no significant death in healthy brain microvascular endothelial cells. In vivo, when tested on a xenograft mouse model, IL13-conjugated Dp44mT-NPs reduced the glioma tumor growth by approximate to 62% while their untargeted counterparts reduced the tumor growth by only approximate to 16%. Notably, this formulation does not cause any significant weight loss or kidney/liver toxicity in mice, demonstrating its great therapeutic potential.This publication has 53 references indexed in Scilit:
- Co3O4 nanocages with highly exposed {110} facets for high-performance lithium storageScientific Reports, 2013
- Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalizationScientific Reports, 2013
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptorProceedings of the National Academy of Sciences of the United States of America, 2013
- Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)International Journal of Molecular Sciences, 2012
- Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain BarrierCancer Research, 2009
- Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cellsAmerican Journal of Hematology, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences of the United States of America, 2006
- Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic AgentsCancer Investigation, 2005
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976